22OCT

StirlingX raises £15m for defence data

1 min read

16:30UTC

StirlingX, founded in 2025, raised a £15m Series A for a sovereign defence-data platform, led by Ventura Capital with Rokos Capital Management.

← Back to Stryker agrees option to buy CMR Surgical Jump to analysis ↓

TechnologyDeveloping

Key takeaway

Sovereignty branding pulled a £15m Series A into a defence-data startup barely a year old.

StirlingX, founded in 2025, raised a £15m Series A for a sovereign data and autonomy platform aimed at defence and critical national infrastructure operators⁠¹. Ventura Capital, a UK venture firm, led, alongside Rokos Capital Management, the private-markets arm of the London hedge fund.

Sovereign here means data systems that stay under national control rather than running on foreign cloud platforms, a pitch pulling capital from buyers who want that guarantee.

A company barely a year old raising at Series A on a national-security thesis signals where allied capital now moves, the same appetite that put the National Wealth Fund's first defence cheque into Rowden Technologies. The procurement questions belong to the defence beat; the investment signal is that sovereignty branding now clears a Series A on its own.

Deep Analysis

In plain English

StirlingX builds computer systems that help the UK government and defence organisations store and use sensitive data securely, without depending on cloud services based overseas, an approach known as 'sovereign' data. The company, founded in 2025, raised £15m to build this platform, backed entirely by British investors Ventura Capital and Rokos Capital Management, and is aimed at defence and critical national infrastructure operators such as power grids and water systems.

Deep Analysis

Root Causes

The Ministry of Defence's shift toward buying software and data platforms from smaller specialist suppliers, rather than exclusively through large prime contractors, has created demand for sovereign infrastructure that does not depend on foreign-owned cloud providers to store sensitive government and critical-infrastructure data.

Ventura Capital and Rokos Capital Management, both already invested in adjacent UK national-security software, are positioned to fund that demand directly, without needing state co-investment the way Rowden Technologies needed the National Wealth Fund to underwrite its first defence contracts.

Sources:UKTN

Mentions:StirlingX →IQ Capital →Schroders Capital →Fractile →Rowden Technologies →NATO →London →UK National Wealth Fund →

First Reported In

Update #10 · AI takes record 44% as UK equity shrinks

UKTN· 4 Jul 2026

Read original →

Causes and effects

Caused by

Fractile lands NATO and CIA chip cash

Fractile's allied-capital cap table established the same national-security investor appetite that funded StirlingX's Series A.

Occurred 13 May 2026

Read story →

This Event

StirlingX raises £15m for defence data

A company barely a year old raising Series A on a national-security pitch shows allied capital chasing sovereign-data ventures.

Led to

Helsing picks Plymouth for £350m plant

StirlingX's sovereign-defence-data raise sits in the same defence-capital pattern as Helsing's Plymouth commitment.

Occurred 13 Jul 2026

Read story →

Different Perspectives

Abu Dhabi Investment Council

The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.

CDP Venture Capital

CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.

EDBI

Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.

Forbion

Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.

British Business Bank

The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.

Stryker Corporation

Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.